200 related articles for article (PubMed ID: 1510457)
1. Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I.
Fukasawa M; Sumita Y; Harabe ET; Tanio T; Nouda H; Kohzuki T; Okuda T; Matsumura H; Sunagawa M
Antimicrob Agents Chemother; 1992 Jul; 36(7):1577-9. PubMed ID: 1510457
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex.
Hikida M; Kawashima K; Yoshida M; Mitsuhashi S
J Antimicrob Chemother; 1992 Aug; 30(2):129-34. PubMed ID: 1301069
[TBL] [Abstract][Full Text] [Related]
3. Laboratory data which differentiate meropenem and imipenem.
Edwards JR; Turner PJ
Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504
[TBL] [Abstract][Full Text] [Related]
4. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
Edwards JR
New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of dehydropeptidase-I and comparative in vitro and in vivo stabilities of PS-5 derivatives modified at the C-3 side chain.
Sakamoto M; Yamamoto K; Isshiki K; Tone H; Ishikura T; Fukagawa Y; Yoshioka T
Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):341-8. PubMed ID: 2054858
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
[TBL] [Abstract][Full Text] [Related]
7. Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).
Park SW; We JS; Kim GW; Choi SH; Park HS
Antimicrob Agents Chemother; 2002 Feb; 46(2):575-7. PubMed ID: 11796382
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems--I. 2-Alkoxymethyl derivatives.
Azami H; Tsutsumi H; Matsuda K; Barrett D; Hattori K; Nakajima T; Kuroda S; Kamimura T; Murata M
Bioorg Med Chem; 1997 Nov; 5(11):2069-87. PubMed ID: 9416424
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
[TBL] [Abstract][Full Text] [Related]
10. Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic.
Hikida M; Kawashima K; Nishiki K; Furukawa Y; Nishizawa K; Saito I; Kuwao S
Antimicrob Agents Chemother; 1992 Feb; 36(2):481-3. PubMed ID: 1605616
[TBL] [Abstract][Full Text] [Related]
11. Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.
Agudelo M; Rodriguez CA; Pelaez CA; Vesga O
Antimicrob Agents Chemother; 2014; 58(2):1005-18. PubMed ID: 24277034
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 1beta-methyl-2-[5'-isoxazoloethenylpyrrolidin-3'-ylthio]carbapenems.
Kim DJ; Seo KJ; Lee KS; Shin KJ; Yoo KH; Kim DC; Park SW
Bioorg Med Chem Lett; 2000 Dec; 10(24):2799-802. PubMed ID: 11133095
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.
Kropp H; Sundelof JG; Hajdu R; Kahan FM
Antimicrob Agents Chemother; 1982 Jul; 22(1):62-70. PubMed ID: 7125632
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients.
Moon YS; Chung KC; Gill MA
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S249-55. PubMed ID: 9126700
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
Mitsuhashi S
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
17. Meropenem clinical pharmacokinetics.
Mouton JW; van den Anker JN
Clin Pharmacokinet; 1995 Apr; 28(4):275-86. PubMed ID: 7648757
[TBL] [Abstract][Full Text] [Related]
18. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
19. Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems.
Wildonger KJ; Ratcliffe RW
J Antibiot (Tokyo); 1993 Dec; 46(12):1866-82. PubMed ID: 8294246
[TBL] [Abstract][Full Text] [Related]
20. CP0569, a new broad-spectrum injectable carbapenem. Part 1: synthesis and structure-activity relationships.
Aihara K; Kano Y; Shiokawa S; Sasaki T; Setsu F; Sambongi Y; Ishii M; Tohyama K; Ida T; Tamura A; Atsumi K; Iwamatsu K
Bioorg Med Chem; 2003 Aug; 11(16):3475-85. PubMed ID: 12878141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
